Heparin-binding motif mutations of human diamine oxidase allow the development of a first-in-class histamine-degrading biopharmaceutical.

Elisabeth GludovaczKornelia SchuetzenbergerMarlene ReschKatharina TillmannKarin PetrocziMarkus SchossererSigrid VondraSerhii VakalGerald KlanertJürgen PollheimerTiina A SalminenBernd JilmaNicole BorthThomas Boehm

Published in: eLife (2021)

Austrian Science Fund (FWF) Hertha Firnberg program grant T1135 (EG); Sigrid Juselius Foundation, Medicinska Understödsförening Liv och Hälsa rft (TAS and SeV).

Keyphrases

endothelial cells
public health
induced pluripotent stem cells
health insurance
quality improvement